文献速递心脏核医学肿瘤 PET/CT

动态铷-82心脏PET/CT测量的心肺通过时间可预测肺动脉高压

Cardiopulmonary transit time measured on dynamic rubidium cardiac PET/CT is a predictor for pulmonary hypertension.
PubMed 文献 · EJNMMI Res · 2026-06-22

本研究回顾性纳入111例在31天内接受[82Rb]PET/CT和超声心动图检查的患者,计算心率归一化心肺通过时间(NCPTT)。结果显示NCPTT延长与左心室射血分数降低、体重增加、左右心室收缩功能障碍及肺动脉压升高相关,提示NCPTT可作为评估心脏功能和筛查肺动脉高压的附加标志物。

要点

  • NCPTT延长与左心室射血分数降低和体重增加显著相关。
  • NCPTT与左右心室收缩功能障碍及肺动脉压升高独立相关。
  • NCPTT或可作为疑似收缩性心功能障碍和肺动脉高压的附加评估指标。

核心结论

  • NCPTT可能作为评估心脏功能(尤其是射血分数)的有用附加标志物,并有助于疑似收缩性心功能障碍患者的评估及肺动脉高压的检测。

研究设计与样本

  • 回顾性单中心研究,纳入111例(72男,39女)在31天内接受[82Rb]RbCl-PET/CT和超声心动图检查的患者。

主要发现

  • NCPTT延长与较低左心室射血分数和较高体重显著相关(p<0.05)。
  • NCPTT与左心室收缩功能障碍显著相关(OR=1.21,95%CI:1.04-1.42,p<0.05)。
  • NCPTT与右心室收缩功能障碍显著相关(OR=1.18,95%CI:1.04-1.34,p<0.01)。
  • NCPTT与肺动脉压升高显著相关(OR=1.21,95%CI:1.02-1.44,p<0.05),与可能肺动脉高压相关(p<0.05),但与左心室舒张功能障碍无关。

临床怎么用

  • 在[82Rb]心脏PET/CT中可计算NCPTT,作为评估心脏收缩功能和筛查肺动脉高压的附加指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cardiopulmonary transit time (CPTT), the time for blood to circulate from the right to the left ventricle, can be assessed on dynamic Rubidium-82 ([82Rb]) cardiac PET/CT. Given its association with cardiac and pulmonary function, CPTT holds potential as a screening marker for pulmonary hypertension. This study investigated the relationship between CPTT and echocardiographic markers of cardiac function, as well as its association with pulmonary hypertension. In this retrospective single-center study, 111 patients (72 male, 39 female) referred for [82Rb]RbCl-PET/CT and echocardiography within 31 days were included. CPTT, normalized to heart rate (NCPTT), was calculated from peak right and left ventricular [82Rb] activity and examined in relation to patient characteristics and echocardiographic parameters, which were further used to categorize left and right ventricular systolic dysfunction, left ventricular diastolic dysfunction, and signs of elevated pulmonary arterial pressure. RESULTS: Prolonged NCPTT was significantly associated with lower left ventricular ejection fraction and increased body weight (p < 0.05). NCPTT was significantly associated with left and right ventricular systolic dysfunction (OR = 1.21, 95%CI:1.04-1.42, p < 0.05; OR = 1.18, 95%CI:1.04-1.34, p < 0.01), elevated pulmonary arterial pressure (OR = 1.21, 95%CI:1.02-1.44, p < 0.05), and possible pulmonary hypertension (p < 0.05), but not with left ventricular diastolic dysfunction. CONCLUSION: Our findings suggest that NCPTT may serve as a useful additional marker for assessing cardiac function, particularly ejection fraction, and could help in the evaluation of patients with suspected cardiac systolic dysfunction, as well as the detection of pulmonary hypertension.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Seige LC, Heimer J, Murray K, et al. Cardiopulmonary transit time measured on dynamic rubidium cardiac PET/CT is a predictor for pulmonary hypertension. EJNMMI Res. 2026. PMID: 42329326. doi:10.1186/s13550-026-01387-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。